Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Friedrich Mittermayer

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
Clinical Science (London, England : 1979)|February 24, 2006
Increased visfatin concentrations in women with gestational diabetes mellitusKatarzyna Krzyzanowska, Walter Krugluger, Friedrich Mittermayer, et al.
Atherosclerosis|January 18, 2006
Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetesKatarzyna Krzyzanowska, Friedrich Mittermayer, Walter Krugluger, et al.
Critical Care Medicine|September 9, 2005
Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascitesArnulf Ferlitsch, Johannes Pleiner, Friedrich Mittermayer, et al.
Circulation|November 3, 2004
Simvastatin prevents vascular hyporeactivity during inflammationJohannes Pleiner, Georg Schaller, Friedrich Mittermayer, et al.
Journal of the American Society of Nephrology : JASN|April 29, 2005
Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patientsFriedrich Mittermayer, Georg Schaller, Johannes Pleiner, et al.
Renal Failure|October 26, 2011
A transient improvement in renal function occurs after ischemic strokeDominik Georg Haider, Julia Ferrari, Friedrich Mittermayer, et al.
Current Diabetes Reviews|December 25, 2014
Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under developmentFriedrich Mittermayer, Erica Caveney, Claudia De Oliveira, et al.
European Journal of Clinical Investigation|July 24, 2010
Forearm vasodilator reactivity in homozygous carriers of the 9p21.3 rs1333049 G>C polymorphismStefan Aschauer, Friedrich Mittermayer, Claudia C Wagner, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 5, 2006
The cardiovascular risk marker asymmetrical dimethylarginine is not affected by venous thromboembolismDominik G Haider, Robert A Bucek, Markus Reiter, et al.
Wiener Klinische Wochenschrift|August 28, 2007
Impaired vascular nitric oxide bioactivity in women with previous gestational diabetesJohannes Pleiner, Friedrich Mittermayer, Herbert Langenberger, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
Clinical Science (London, England : 1979)|February 24, 2006
Increased visfatin concentrations in women with gestational diabetes mellitusKatarzyna Krzyzanowska, Walter Krugluger, Friedrich Mittermayer, et al.
Atherosclerosis|January 18, 2006
Asymmetric dimethylarginine is associated with macrovascular disease and total homocysteine in patients with type 2 diabetesKatarzyna Krzyzanowska, Friedrich Mittermayer, Walter Krugluger, et al.
Critical Care Medicine|September 9, 2005
Vasoconstrictor hyporeactivity can be reversed by antioxidants in patients with advanced alcoholic cirrhosis of the liver and ascitesArnulf Ferlitsch, Johannes Pleiner, Friedrich Mittermayer, et al.
Circulation|November 3, 2004
Simvastatin prevents vascular hyporeactivity during inflammationJohannes Pleiner, Georg Schaller, Friedrich Mittermayer, et al.
Journal of the American Society of Nephrology : JASN|April 29, 2005
Asymmetrical dimethylarginine plasma concentrations are related to basal nitric oxide release but not endothelium-dependent vasodilation of resistance arteries in peritoneal dialysis patientsFriedrich Mittermayer, Georg Schaller, Johannes Pleiner, et al.
Renal Failure|October 26, 2011
A transient improvement in renal function occurs after ischemic strokeDominik Georg Haider, Julia Ferrari, Friedrich Mittermayer, et al.
Current Diabetes Reviews|December 25, 2014
Addressing unmet medical needs in type 2 diabetes: a narrative review of drugs under developmentFriedrich Mittermayer, Erica Caveney, Claudia De Oliveira, et al.
European Journal of Clinical Investigation|July 24, 2010
Forearm vasodilator reactivity in homozygous carriers of the 9p21.3 rs1333049 G>C polymorphismStefan Aschauer, Friedrich Mittermayer, Claudia C Wagner, et al.
Translational Research : the Journal of Laboratory and Clinical Medicine|August 5, 2006
The cardiovascular risk marker asymmetrical dimethylarginine is not affected by venous thromboembolismDominik G Haider, Robert A Bucek, Markus Reiter, et al.
Wiener Klinische Wochenschrift|August 28, 2007
Impaired vascular nitric oxide bioactivity in women with previous gestational diabetesJohannes Pleiner, Friedrich Mittermayer, Herbert Langenberger, et al.
Pageof 4